Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Naja Nyffenegger

1PUBLICATIONS

3CO-AUTHORS

Haematology

Featured researcher

Get your video featured.

Publish with JoVE

Featured researcher

Get your video featured.

Publish with JoVE

Publications (1)

Sort by Publication Date:

|Jun 17, 2022

The oral ferroportin inhibitor vamifeport improves hemodynamics in a mouse model of sickle cell disease.

Naja Nyffenegger, Rahima Zennadi, Natarajaswamy Kalleda

Pageof 1

Frequent Collaborators

1 joint publications

Rahima Zennadi

1 joint publications

Raphael M Buzzi

1 joint publications

Vania Manolova

Frequent Collaborators

1 joint publications

Rahima Zennadi

1 joint publications

Raphael M Buzzi

1 joint publications

Vania Manolova

Top Related Videos

A Precision Medicine Tool for Measurement and Monitoring of Hemoglobin S in Sickle Cell Disease Patients Receiving Transfusion Therapy

A Precision Medicine Tool for Measurement and Monitoring of Hemoglobin S in Sickle Cell Disease Patients Receiving Transfusion Therapy

See more related videos

Top Related Videos

A Precision Medicine Tool for Measurement and Monitoring of Hemoglobin S in Sickle Cell Disease Patients Receiving Transfusion Therapy

A Precision Medicine Tool for Measurement and Monitoring of Hemoglobin S in Sickle Cell Disease Patients Receiving Transfusion Therapy

See more related videos